loader image
Sunday, February 1, 2026
45.5 F
McAllen
- Advertisement -

Paxton Secures $41.5M from Pfizer & Tris Pharma for Providing Adulterated Drugs to Children

Translate to Spanish or other 102 languages!

Following Attorney General Paxton’s lawsuit, Pfizer and Tris Pharma have agreed to pay $41.5 million and ensure that they follow all state and federal laws related to the manufacturing and distribution of drugs. Image for illustration purposes
- Advertisement -

AUSTIN – Attorney General Ken Paxton has secured a $41.5 million settlement with Pfizer and Tris Pharma for allegedly providing adulterated pharmaceutical drugs to Texas children in violation of the Texas Health Care Program Fraud Prevention Act (“THFPA”).    

“I will never back down from taking on the biggest corporations in the world that deceive and take advantage of Texans. Pfizer and Tris Pharma provided adulterated drugs to children for years and changed test results in order to obtain the benefit of taxpayer-funded Medicaid reimbursement,” said Attorney General Paxton. “Under my watch, Big Pharma will not escape justice for lying about the effectiveness of its drugs.”  

In November 2023, Attorney General Paxton sued Pfizer and Tris Pharma, alleging that the pharmaceutical companies had knowingly provided an ADHD medication named Quillivant XR to children on Medicaid despite the drug’s pattern of failing quality control tests due to flawed manufacturing practices. The lawsuit alleged that from 2012 to 2018, Pfizer and Tris altered the drug’s testing method in violation of federal and state laws to ensure Quillivant satisfied regulatory hurdles and could continue to be sold.   

- Advertisement -

Following Attorney General Paxton’s lawsuit, Pfizer and Tris Pharma have agreed to pay $41.5 million and ensure that they follow all state and federal laws related to the manufacturing and distribution of drugs.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

CDC Tops 1 Million Voluntary Participants in Traveler Genomic Surveillance Program

The Centers for Disease Control and Prevention (CDC) today announced that its Traveler-Based Genomic Surveillance (TGS) program has surpassed one million voluntary participants, marking a significant milestone in the United States' ability to detect and respond to emerging public health threats at our borders.

STHS Heart Launches Heart Saver Initiative with $49 Cardiac CT Screenings Thru Feb. 28th

Rising rates of obesity, hypertension and diabetes in the United States have resulted in an increasing prevalence of heart disease across the nation, especially among young adults.

Simple Habits That Make Falling Asleep Easier

Mega Doctor News CLEVELAND CLINIC - Struggling to fall asleep at night once...

Annual VAMOS Golf Tournament Drives Funding for First-Generation College Students

The Valley Alliance of Mentors for Opportunities and Scholarships (VAMOS) recently announced that it will host its 30th Annual VAMOS Golf Tournament, on Saturday, March 7, 2026 at Champion Lakes Golf Course in McAllen, Texas.
- Advertisement -
×